Favorable Outcome in Replication Repair Deficient Hypermutant Tumors to Immune Checkpoint Inhibition: An International RRD Consortium Registry Study
S. Sudhaman,D. Morgenstern,J. Chung, L. Nobre, N. Alsafwani, J. Kelly,A. Coblentz,M. Edwards,V. Bianchi, T. Lipman, C. Zhang,A. Ercan, L. Sambira,A. Bendel, S. Bielack, E. Koustenis,D. Blumenthal,D. Bowers,A. Broniscer, A. Bronsema, S. Carroll,S. Chiaravalli,K. Cole,S. Constantini, R. Loret De Mola, G. Dunn, C. Frojd, D. Gass, K. Gauvain,B. George,N. Hijiya, L. Hoffman,J. Knipstein,T. Laetsch,V. Larouche,A. Lassaletta,S. Luna-Fineman, V. M. Issai,G. Mason,W. Mason,M. Massimino,O. Mordechai,E. Opocher, M. Oren,M. Osborn,A. Reddy,M. Remke,S. Roy,M. Sabel,D. Samuel, K. Schneider,S. Sen, D. Stearns, D. Sumerauer, G. Thomas,P. Tomboc,A. Van Damme, M. Wierman, I. Winer, L. Yen,M. Zapotocky,D. Ziegler, S. Zimmermann, R. Dvir, G. Rechavi,C. Durno,M. Aronson,M. Taylor,P. Dirks,T. Pugh,A. Shlien,C. Hawkins,E. Bouffet, U. Tabori PEDIATRIC BLOOD & CANCER（2020）
AI 理解论文
溯源树
样例
